Rebalix
Logo UBSUBS · sheet of 5 September 2026
ETF sheet · official issuer and register data

UBS MSCI ACWI SF UCITS ETF USD acc

IE00BYM11H29 · IE00BYM11H29 · USD · domicile Ireland
Equity · GlobalSFDR art. 6
Index tracked: MSCI ACWI Total Return Net Index
TER
0.21%+ trans. 0.00%
Fund size
3.9 bn EUR
Tracking difference
+0.03%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 1 Nov 2018 · costs from the KID as of 2 Sept 2026 · 0 securities held · 4 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The objective of the Fund is capital appreciation. The Fund tracks the daily performance of an equity index, called the MSCI ACWI Net Total Return Index (the 'Index'), less fees and costs and consequently is passively managed. The Fund invests in financial derivative instruments ('FDIs') with UBS AG, London Branch ('UBS') as counterparty. The Fund may also invest in securities (e.g. company shares and bonds issued by companies and governments). Under the terms of the FDIs, the performance of the Index is swapped from UBS to the Fund, and in return the…

Performance since series start (in euro) — base 100

1 Nov 20183 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
201920212023202526485263
High 264 (12 Aug 2026) · low 85 (23 Mar 2020) · last 263. Past performance is not indicative of future results.

Returns in euro

1 year+24.1%
3 years+63.9%
5 years+70.8%
10 yearsseries too young
Since series start+162.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.46%12.07%13.76%
Max drawdown−9.29%−16.07%−26.38%
Sharpe1.671.330.63
Sortino2.491.910.89
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BYM11H29 · IE00BYM11H291
RebalixIE00BYM11H29 · IE00BYM11H29 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+22.33%+22.34%−0.01%
2024+17.55%+17.49%+0.06%
2023+22.24%+22.20%+0.04%
2022−18.38%−18.36%−0.02%
2021+18.46%+18.54%−0.08%

Holdings

Portfolio as declared by the issuer · 31 Jul 2026 · 0 securities · top-10 weight = 24.2%
Top holdingsWeight
NVIDIA4.6%
APPLE4.5%
MICROSOFT CORP3.2%
AMAZON.COM2.6%
ALPHABET A2.0%
TAIWAN SEMICONDUCTOR MFG1.8%
BROADCOM1.7%
ALPHABET C1.6%
META PLATFORMS A1.2%
JPMORGAN CHASE & CO0.9%
Countries (% of fund)
Stati Uniti63.6%Giappone5.1%Regno Unito3.2%Taiwan3.1%Canada3.0%
Sectors (% of fund)
Tecnologia dell'informazio…30.3%Servizi Finanziari17.2%Industriali10.9%Beni di consumo9.0%Sanità8.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
ACWIA · Borsa Italiana (ETFplus)
5880 · Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 6 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ubs.com/2/e/priip/PRIIPSEU_IE00BYM11H29_en_IE.pdf
Factsheet · www.ubs.com/2/e/files/RET/FS_RET_IE00BYM11H29_IT_IT.pdf
Prospectus · www.ubs.com/2/e/files/ubs_etfs_plc_peit.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BYM11H29
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE00BYM11H29 · IE00BYM11H292